Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Lohse

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Neuropharmacology|October 15, 2011
Efficacy of parecoxib, sumatriptan, and rizatriptan in the treatment of acute migraine attacksThomas Müller, Lutz Lohse
Biomolecules|August 6, 2021
Vitamin D and Blood ParametersThomas Müller, Lutz Lohse, Andreas Blodau, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 18, 2019
Vitamin D rise enhances blood perfusion in patients with multiple sclerosisThomas Müller, Lutz Lohse, Andreas Blodau, et al.
Therapeutic Advances in Neurological Disorders|July 2, 2016
One-time intrathecal triamcinolone acetonide application alters the redox potential in cerebrospinal fluid of progressive multiple sclerosis patients: a pilot studyThomas Müller, Thomas Herrling, Sven Lütge, et al.
Clinical Neuropharmacology|January 18, 2014
Reduction in the free radical status and clinical benefit of repeated intrathecal triamcinolone acetonide application in patients with progressive multiple sclerosisThomas Müller, Thomas Herrling, Sven Lütge, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Neuropharmacology|October 15, 2011
Efficacy of parecoxib, sumatriptan, and rizatriptan in the treatment of acute migraine attacksThomas Müller, Lutz Lohse
Biomolecules|August 6, 2021
Vitamin D and Blood ParametersThomas Müller, Lutz Lohse, Andreas Blodau, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 18, 2019
Vitamin D rise enhances blood perfusion in patients with multiple sclerosisThomas Müller, Lutz Lohse, Andreas Blodau, et al.
Therapeutic Advances in Neurological Disorders|July 2, 2016
One-time intrathecal triamcinolone acetonide application alters the redox potential in cerebrospinal fluid of progressive multiple sclerosis patients: a pilot studyThomas Müller, Thomas Herrling, Sven Lütge, et al.
Clinical Neuropharmacology|January 18, 2014
Reduction in the free radical status and clinical benefit of repeated intrathecal triamcinolone acetonide application in patients with progressive multiple sclerosisThomas Müller, Thomas Herrling, Sven Lütge, et al.
Pageof 1